Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
P-Gemox vs EPOCH in Early Stage NK/T-cell Lymphoma
NCT02359162Phase 3Terminated
- Sponsor
- Sun Yat-sen University
- Start
- May 2015
- Primary completion
- Jun 2017
- Modality
- DNA Intercalators/Alkylators, Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, oxaliplatin, pegaspargase in Extranodal NK/T-cell lymphoma (ENKTL), sponsored by Sun Yat-sen University. Started May 2015; status: terminated.
02
Drugs
gemcitabineoxaliplatinpegaspargase
03
Conditions
Extranodal NK/T-cell lymphoma (ENKTL)
Beyond the preview
Go deeper on NCT02359162.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359162.